Prosecution Insights
Prosecution Insights
26 pending office actions • 19 art units • 26 examiners • 0 of 26 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (4%) |
| §103 only | 7 (27%) |
| §102 only | 1 (4%) |
| §112 only | 3 (12%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 13 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WARD, PAUL V | 1 | 83.1% | -11.9% |
| WRIGHT, SARAH C | 1 | 41.4% | +46.2% |
| TOWNSLEY, SARA ELIZABETH | 1 | 24.9% | +48.9% |
| O'HERN, BRENT T | 1 | 78.2% | +20.1% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| SEITZ, ANTHONY JOSEPH | 1 | 68.1% | +27.6% |
| TRIVISONNO, ANGELO | 1 | 53.0% | +25.5% |
| HOFFA, ANGELA MARIE | 1 | 67.7% | +27.6% |
| HABTE, KAHSAY | 1 | 85.0% | +7.4% |
| PRIEST, AARON A | 1 | 61.1% | +25.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18259836 | STABLE EFFICIENT COSMETIC PREPARATIONS | CHANG, KYUNG SOOK | 160d overdue |
| 18007152 | INJECTION MOLDING OF MEAT-LIKE FOOD PRODUCTS | BECKER, DREW E | 119d overdue |
| 17765625 | LIPOSOMAL CANNABINOIDS AND USES THEREOF | MITCHELL, EDWIN COLEMAN | 98d overdue |
| 18217575 | DIAGNOSTIC USE OF CELL FREE DNA CHROMATIN IMMUNOPRECIPITATION | PRIEST, AARON A | 15d overdue |
| 18247494 | PROTEIN-BOUND CANNABINOID FORMULATIONS AND USES THEREOF | SHEIKH, HUMERA N | 14d |
| 18040810 | CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING | LEE, JAE W | 15d |
| 18005197 | ORAL CAVITY POLYMERIC DELIVERY SYSTEMS | BOATENG, AFUA BAMFOAA | 20d |
| 18624587 | PROTECTIVE COATING FOR PLANTS AND POSTHARVEST PLANT MATTER | O'HERN, BRENT T | 75d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286618 | MRI BASED SYSTEM AND METHOD FOR DETECTING IRON-RELATED ENTITIES IN A REGION OF INTEREST | HOFFA, ANGELA MARIE | 77d overdue |
| 18217575 | DIAGNOSTIC USE OF CELL FREE DNA CHROMATIN IMMUNOPRECIPITATION | PRIEST, AARON A | 15d overdue |
| 18746146 | FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS | WRIGHT, SARAH C | 34d |
| 18624587 | PROTECTIVE COATING FOR PLANTS AND POSTHARVEST PLANT MATTER | O'HERN, BRENT T | 75d |
| 18559809 | PEROVSKITE COMPOSITIONS AND USES THEREOF IN PHOTOVOLTAIC DEVICES | TRIVISONNO, ANGELO | 83d |
| 18699294 | ARYLATED FENCHONE DERIVATIVES, COMPOSITIONS COMPRISING THEM, PROCESSES FOR THEIR PREPARATION AND USES THEREOF | TOWNSLEY, SARA ELIZABETH | — |
| 18290220 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | SEITZ, ANTHONY JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| 1793 | 2 |
| 1632 | 2 |
| 1624 | 2 |
| 1613 | 2 |
| 1617 | 2 |
| 1622 | 1 |
| 1629 | 1 |
| 1722 | 1 |
| 3799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18833008 | METAP2 INHIBITORS AND USES THEREOF | WARD, PAUL V | — | §102§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18746146 | FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | 34d | Pending | Jun 18, 2024 |
| 18699294 | ARYLATED FENCHONE DERIVATIVES, COMPOSITIONS COMPRISING THEM, PROCESSES FOR THEIR PREPARATION AND USES THEREOF | TOWNSLEY, SARA ELIZABETH | 1622 | §103 | Non-Final OA | — | Pending | Apr 07, 2024 |
| 18624587 | PROTECTIVE COATING FOR PLANTS AND POSTHARVEST PLANT MATTER | O'HERN, BRENT T | 1793 | §102§103§112 | Non-Final OA | 75d | Pending | Apr 02, 2024 |
| 18598152 | CARDIAC ORGANOID AND ANTI-ELECTRO-MITOCHONDRIAL DESYNCHRONIZATION THERAPY | WRIGHT, ERIC BRANDON | 1632 | §101§102 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18290220 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | SEITZ, ANTHONY JOSEPH | 1629 | §102 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18559809 | PEROVSKITE COMPOSITIONS AND USES THEREOF IN PHOTOVOLTAIC DEVICES | TRIVISONNO, ANGELO | 1722 | §102§103§112 | Final Rejection | 83d | Pending | Nov 09, 2023 |
| 18286618 | MRI BASED SYSTEM AND METHOD FOR DETECTING IRON-RELATED ENTITIES IN A REGION OF INTEREST | HOFFA, ANGELA MARIE | 3799 | §103 | Final Rejection | 77d overdue | Pending | Oct 12, 2023 |
| 18554199 | THERAPEUTIC MODALITIES FOR INHIBITING PANCREATIC BETA CELL IMPAIRMENT AND TREATING DIABETES | HABTE, KAHSAY | 1624 | §102§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18217575 | DIAGNOSTIC USE OF CELL FREE DNA CHROMATIN IMMUNOPRECIPITATION | PRIEST, AARON A | 1681 | §102§103 | Final Rejection | 15d overdue | Pending | Jul 02, 2023 |
| 18259836 | STABLE EFFICIENT COSMETIC PREPARATIONS | CHANG, KYUNG SOOK | 1613 | §102§103 | Non-Final OA | 160d overdue | Pending | Jun 29, 2023 |
| 18253146 | EXTREMELY FAST SOLID PHASE SYNTHESIS | VARADARAJ, ARCHANA | 1658 | §103DP | Non-Final OA | 14d | Pending | May 16, 2023 |
| 18251427 | MODIFIED CARBON-BASED MATERIALS | HENDRICKSON, STUART L | 1736 | §102§103§112 | Non-Final OA | — | Pending | May 02, 2023 |
| 18247494 | PROTEIN-BOUND CANNABINOID FORMULATIONS AND USES THEREOF | SHEIKH, HUMERA N | 1784 | §102§103 | Non-Final OA | 14d | Pending | Mar 31, 2023 |
| 18020734 | METHOD FOR THE TREATMENT OF WWOX ASSOCIATED DISEASES | BATES, KEENAN ALEXANDER | 1631 | §103 | Final Rejection | — | Pending | Feb 10, 2023 |
| 18040810 | CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING | LEE, JAE W | 1656 | §102§103§112 | Non-Final OA | 15d | Pending | Feb 06, 2023 |
| 18007152 | INJECTION MOLDING OF MEAT-LIKE FOOD PRODUCTS | BECKER, DREW E | 1792 | §103§112 | Final Rejection | 119d overdue | Pending | Jan 27, 2023 |
| 18098184 | METHODS OF CULTURING PROBIOTIC BACILLI | TURNER, FELICIA C | 1793 | §103 | Final Rejection | 34d | Pending | Jan 18, 2023 |
| 18005197 | ORAL CAVITY POLYMERIC DELIVERY SYSTEMS | BOATENG, AFUA BAMFOAA | 1617 | §103§112 | Non-Final OA | 20d | Pending | Jan 12, 2023 |
| 17765625 | LIPOSOMAL CANNABINOIDS AND USES THEREOF | MITCHELL, EDWIN COLEMAN | 1619 | §103§112 | Non-Final OA | 98d overdue | Pending | Mar 31, 2022 |
| 17634414 | PHYTOCANNABINOIDS FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE, DYSLIPIDEMIA, AND TYPE 2 DIABETES | BRAUN, MADELINE E | 1624 | §112 | Non-Final OA | — | Pending | Feb 10, 2022 |
| 17597878 | ANTICANCER AGENTS | CREWS, JARET JAMES | 1691 | §103 | Final Rejection | 70d overdue | Pending | Jan 27, 2022 |
| 17503581 | CONJUGATES OF AUXIN ANALOGS | FAY, ZOHREH ALEMZADEH | 1617 | §112 | Final Rejection | — | Pending | Oct 18, 2021 |
| 17604183 | SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS | BERRIOS, JENNIFER A | 1613 | §103 | Non-Final OA | 25d overdue | Pending | Oct 15, 2021 |
| 17427405 | NEOANTIGENS CREATED BY ABERRANT-INDUCED SPLICING AND USES THEREOF IN ENHANCING IMMUNOTHERAPY | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Final Rejection | — | Pending | Jul 30, 2021 |
| 16980401 | COMPOUNDS AND USES FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS ASSOCIATE WITH OR AGGREVATED BY IMPARED MITOPHAGY | YOO, SUN JAE | 1621 | §112 | Non-Final OA | 141d overdue | Pending | Sep 13, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial